About State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
During the past decade, State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on
average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
2011-06-01
2018-04-10
Completed
797
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
2017-02-03
2019-12-26
Completed
326
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
2016-09-15
2021-08-01
Terminated
243
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
2018-06-27
2022-10-13
Terminated
76
A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004)
2021-05-12
2027-11-30
Recruiting
700
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
2021-12-01
2026-12-31
Recruiting
200
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
2021-12-29
2025-09-09
Recruiting
150
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department" #1 sponsor was "R-Pharm International, LLC" with 4 trials, followed by "Kowa Research Institute, Inc." with 2 trials
sponsored, "Biocad" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Gilead Sciences"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department"
#1 collaborator was "OCT Clinical Trials" with 4 trials as a collaborator, "Quintiles, Inc." with 3 trials as a collaborator, "Mene Research" with 2 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
According to Clinical.Site data, the most researched conditions in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department" are
"Rheumatoid Arthritis" (4 trials), "COVID-19" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Angina Pectoris" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department" in a lesser frequency.
Clinical Trials Intervention Types at State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
Most popular intervention types in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Olokizumab" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
The vast majority of trials in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department" are
10 trials for "All" genders.
Clinical Trials Status at State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department
Currently, there are NaN active trials in "State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in State Budgetary Healthcare Institution "City Clinical Hospital # 15 n.a O.M. Filatov" of Moscow Healtheare Department, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".